Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,462 | 14,875 | 25,618 | 21,394 | 3,709 |
| Marketable Securities | 18,801 | 20,000 | N/A | N/A | N/A |
| Receivables | N/A | N/A | 19,335 | 23,471 | N/A |
| Inventories | N/A | N/A | 17,654 | 25,840 | N/A |
| Other current assets | 0 | 0 | 9,678 | 11,446 | 95,414 |
| TOTAL | $33,869 | $35,992 | $82,928 | $86,857 | $99,523 |
| Non-Current Assets | |||||
| PPE Net | 2 | 17 | 13,944 | 15,067 | 31 |
| Other Non-Current Assets | 15,878 | 15,000 | 1,261 | 1,562 | 1,075 |
| TOTAL | $15,880 | $15,017 | $15,205 | $16,629 | $1,106 |
| Total Assets | $49,749 | $51,009 | $98,133 | $103,486 | $100,629 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4 | 16,753 | 8,188 | 5 |
| Accounts payable and accrued liabilities | 68 | 364 | 24,663 | 17,443 | 696 |
| Accrued Expenses | 399 | 442 | 8,600 | 16,737 | 2,937 |
| Other current liabilities | 3,564 | 311 | 31,718 | 33,439 | 69,220 |
| TOTAL | $4,033 | $1,253 | $85,779 | $79,947 | $73,353 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 51 | 73 | 2 |
| Other Non-Current Liabilities | 45,716 | 85 | 2,093 | 2,759 | 263 |
| TOTAL | $45,716 | $85 | $2,144 | $2,832 | $265 |
| Total Liabilities | $49,749 | $1,338 | $87,923 | $82,779 | $73,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,235 | 8,235 | 8,174 | 8,174 | 8,174 |
| Common Shares | N/A | 824 | 818 | 818 | 818 |
| Retained earnings | N/A | -21,802 | -61,203 | -51,813 | -46,658 |
| Other shareholders' equity | 0 | 13,951 | 13,897 | 15,105 | 16,361 |
| TOTAL | $N/A | $49,671 | $10,210 | $20,707 | $27,011 |
| Total Liabilities And Equity | $49,749 | $51,009 | $98,133 | $103,486 | $100,629 |